Education & Training

Search for Educational Activities and Resources:

Filter by Target Audience

Please select the option that best aligns with your profession.

Filter by Topic

Please select the option that best aligns with your topic of interest.

If a subtopic exists for your primary topic, it will automatically display below.

Filter by Format

Please select the option that best aligns with your preferred format of training.

Continue a Training

If you need to access a course in progress, please go directly to our education site.

PCSS-MOUD has the resources and training you need
to meet the needs of your patients.

PCSS-MOUD is a national training and clinical mentoring project developed in response to the opioid use disorder crisis. Made up of a coalition and led by the American Academy of Addiction Psychiatry (AAAP), PCSS-MOUD’s education and training resources are developed for healthcare providers and professionals. The overarching goal of PCSS-MOUD is to provide the most effective evidence-based clinical practices in the prevention of OUD through proper opioid prescribing practices, identifying patients with OUD, and the treatment of opioid use disorder.

Providers Clinical Support System - Medications for Alcohol Use Disorder (PCSS-MAUD)

PCSS-MAUDProviders Clinical Support System – Medications for Alcohol Use Disorder is a national project funded by the Substance Abuse and Mental Health Services Administration to provide free, comprehensive training, guidance, and mentoring on the prevention, diagnosis, and treatment of alcohol use disorder.

Educational Activities by Format

Modules

Designed to enhance providers knowledge and skills in evidence-based treatment practices. Most include CME/CE credit and all offered at no cost.

Podcasts

The PCSS-MOUD Podcast provides insight into challenges around opioid use disorders and pain management.

Webinars

Webinars address a wide range of topics related to clinical practices. Most include CME/CE credit and all are offered at no cost.

Videos

Videos address an array of topics including: stigma, engaging patients and treatment options.

Clinical Guidances

“Clinical practice guidelines are systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”(Institute of Medicine, 1990)

Resources

These resources and sample forms for treating OUD and chronic pain were developed for health professionals, patients, family members and significant others of patients and the general community to learn more about the evidence-based treatment of opioid use disorders and the treatment of chronic pain.

Note: Inclusion on the list does not indicate PCSS-MOUD, AAAP, or partner organizations endorse any of the resources listed and exclusion in no way implies other resources are not available or valuable.

This three-part Learning Community will focus on differential prescribing practices of Medications for Opioid Use Disorder (MOUD) for black patients vs. their counterparts.
Presenter(s):
Elie Aoun, MD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Nursing Contact Hours, Pharmacy CE Credit, Social Work, and IPCE Credit
Substance use disorders and opioid use disorders are more common in LGBTQ+ individuals with comorbid mental illness. In addition, many treatment programs do not have culturally sensitive resources to treat LGBTQ+ patients adequately. They are unaware of resources available for those with other underlying conditions or adverse histories. Micro-aggressions and discrimination in MOUD practice can negatively impact treatment and recovery from substance use disorders. Therefore, it is essential for practitioners to have a greater understanding of this minority population.
Presenter(s):
Cornel Stanciu, MD
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Credit™, AAPA Category 1 CME, Nursing Contact Hours, Pharmacy CE Credit, Social Work, and IPCE Credit
This webinar aims to offer a comprehensive update on kratom, a botanical increasingly prevalent among the US population. There is a significant knowledge gap concerning the intersection of its purported therapeutic benefits and associated risks, including the potential for overdose and addiction. Understanding the current literature on kratom’s use as a harm reduction tool by those with opioid addiction, as well as the toxicities associated with available kratom products in the United States, is crucial. Additionally, we will explore the risk of developing kratom addiction and strategies for effective management. Clinicians will gain the necessary knowledge to engage in informed discussions with kratom users and implement evidence-based treatment approaches for those who develop addiction.
Loading more results